Rewards
Some stock data isn't available right now.

Viking Therapeutics, Inc (VKTX)

Underlying price

$25.17

-2.57% last session

Stock stats

$3.15B
$25.84
$25.62
$24.69 – $26.37
$23.82 – $43.10
3.39M
5.36M
-
-
-$5.42
-
0.782

Analysts & earnings

Analyst ratings

Buy, 4.14 on a scale from 1, strong sell, to 5, strong buy
  • 5 Strong buy
  • 14 Buy
  • 2 Hold
  • 0 Sell
  • 0 Strong sell
$95.32+278.63%
Today
$25.17
Target
$95.32

Earnings per share

Beat estimates 1 of last 4

  • Estimate
  • Actual
  • Feb '26: actual -$1.38, estimate -$0.9
  • Apr '26: actual -$1.37, estimate -$0.91
  • Jul '26: actual -$1.10, estimate -$1.21
  • Oct '26: actual -$1.55, estimate -$1.06

About Viking Therapeutics, Inc

Viking Therapeutics Inc is a healthcare service provider. The company specializes in the area of biopharmaceutical development focused on metabolic and endocrine disorders. The company's clinical program pipeline consists of VK2809, VK5211, and VK0214 products. VK2809 and VK0214 are orally available, tissue and receptor-subtype-selective agonists of the thyroid hormone receptor beta. VK5211 is an orally available, non-steroidal selective androgen receptor modulator.

Ticker
VKTX
Asset class
Equity
Tokenized by
0 issuers
Sector
Healthcare
Industry
Pharmaceutical Preparations
Employees
74